(r)evolution of AAV2 titration ELISA - from monoclonal to recombinant

被引：0
|
作者：
Besir, H. [1 ]
Mueller, N. [1 ]
Loos, N. [1 ]
Queitsch, I. [1 ]
Odenwald, C. [1 ]
Kuhlendahl, S. [1 ]
机构：
[1] PROGEN Biotech GmbH, Heidelberg, Germany
来源：
HUMAN GENE THERAPY | 2018年 / 29卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P413
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [1] (r)Evolution of AAV2 Titration ELISA - From Monoclonal to Recombinant
    Besir, Hueseyin
    Mueller, Nathalie
    Loos, Nina
    Queitsch, Iris
    Odenwald, Caroline
    Kuhlendahl, Sven
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 347 - 347
  • [2] Recombinant AAV2 and the Endoplasmic Reticulum
    Jiang, Hao-Yuan
    Xiang, Yiwen
    Weigel-Van Aken, Kirsten A. K.
    [J]. MOLECULAR THERAPY, 2009, 17 : S38 - S39
  • [3] Re-Administration of Recombinant AAV2 and AAV5 in the Brain
    Reimsnider, Sharon K.
    Manfredsson, Fredric P.
    Burger, Corinna
    Muzczyka, Nicholas
    Mandel, Ronald J.
    [J]. MOLECULAR THERAPY, 2006, 13 : S348 - S348
  • [4] Insertional mutagenesis of AAV2 capsid and the production of recombinant virus
    Rabinowitz, JE
    Xiao, WD
    Samulski, RJ
    [J]. VIROLOGY, 1999, 265 (02) : 274 - 285
  • [5] Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9
    Jan, Asad
    Richner, Mette
    Vaegter, Christian B.
    Nyengaard, Jens R.
    Jensen, Poul H.
    [J]. NEUROSCIENCE INSIGHTS, 2019, 14
  • [6] Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2
    D Grimm
    A Kern
    M Pawlita
    F K Ferrari
    R J Samulski
    J A Kleinschmidt
    [J]. Gene Therapy, 1999, 6 : 1322 - 1330
  • [7] Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2
    Grimm, D
    Kern, A
    Pawlita, M
    Ferrari, FK
    Samulski, RJ
    Kleinschmidt, JA
    [J]. GENE THERAPY, 1999, 6 (07) : 1322 - 1330
  • [8] Directed evolution of AAV2 yields novel capsid variants
    Maheshri, N
    Kaspar, B
    Schaffer, DV
    [J]. MOLECULAR THERAPY, 2004, 9 : S8 - S8
  • [9] Improved method of recombinant AAV2 delivery for systemic targeted gene therapy
    Mah, C
    Fraites, TJ
    Zolotukhin, I
    Song, SH
    Flotte, TR
    Dobson, J
    Batich, C
    Byrne, BJ
    [J]. MOLECULAR THERAPY, 2002, 6 (01) : 106 - 112
  • [10] Does the use of recombinant AAV2 in pulmonary gene therapy damage lung function?
    Lassance, Roberta M.
    Passaro, Caroline P.
    Martini, Sabrina V.
    Castiglione, Raquel C.
    Gutierrez, Tatiana M.
    Abreu, Soraia C.
    Antunes, Mariana A.
    Xisto, Debora G.
    Cebotaru, Liudmila
    Petrs-Silva, Hilda
    Zin, Walter A.
    Guggino, William B.
    Linden, Rafael
    Rocco, Patricia R. M.
    Morales, Marcelo M.
    [J]. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2008, 160 (01) : 91 - 98
12345